1985
DOI: 10.1073/pnas.82.23.8144
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism of action of the group A streptococcal C5a inactivator.

Abstract: Virulent group A streptococci have been found to express a cell-surface factor that has the capability of inactivating complement-derived chemotactic factors. To determine the mechanism ofaction ofthis factor, we examined the interaction of purified inactivator with pure C5a chemotaxin. Ligand-receptor binding studies demonstrated that streptococcal chemotactic factor inactivator (SCFI)-treated C5a expressed a greatly reduced ability to bind to receptors of polymorphonuclear leukocytes as compared with native … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
136
2

Year Published

1994
1994
2020
2020

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 155 publications
(144 citation statements)
references
References 21 publications
6
136
2
Order By: Relevance
“…In contrast to S. aureus, other Gram-positive bacteria like Group A streptococci rather use proteases to protect themselves from complement attack (43,44). For example, streptococcal cysteine protease SpeB degrades C3 to inhibit bacterial clearance (45), whereas the streptococcal cellassociated peptidase ScpA cleaves C5a to inhibit neutrophil chemotaxis (46). In this study, we describe that S. aureus also uses its proteases to dampen the complement response.…”
Section: Discussionmentioning
confidence: 95%
“…In contrast to S. aureus, other Gram-positive bacteria like Group A streptococci rather use proteases to protect themselves from complement attack (43,44). For example, streptococcal cysteine protease SpeB degrades C3 to inhibit bacterial clearance (45), whereas the streptococcal cellassociated peptidase ScpA cleaves C5a to inhibit neutrophil chemotaxis (46). In this study, we describe that S. aureus also uses its proteases to dampen the complement response.…”
Section: Discussionmentioning
confidence: 95%
“…First, they can inhibit effector functions of complement activation. For example, bacterial capsules are thought to act by preventing the insertion of the MAC into the outer membrane (46,47), while Streptococcus pyogenes secretes a protease that directly cleaves C5, the first component of the MAC (48,49). Alternatively, pathogens can recruit negative regulators of the host complement system to their surface.…”
Section: Discussionmentioning
confidence: 99%
“…Proteolytic cleavage of complement components by bacterial proteases is a mechanism used by many human pathogens. Examples are streptococcal cysteine protease SpeB, which degrades C3 to inhibit bacterial clearance (25), the streptococcal cell-associated peptidase ScpA, which cleaves C5a to inhibit neutrophil chemotaxis (26), GelE of Enterococcus faecalis (27) and aureolysin of Staphylococcus aureus, which cleave C3 (28), EspP of enterohemorrhagic E. coli, which cleaves C3 and C5 to impair complement activation (29), and PgtE of Salmonella enterica, which proteolytically cleaves C3b, C4b, and C5 to enhance bacterial resistance to human serum (30).…”
Section: Discussionmentioning
confidence: 99%